Chinese Journal of Hepatology 2010 Issue 8 Effect of ligustrazine hydrocklorde on induced alcoholic fatty liver in vitro

Effect of ligustrazine hydrocklorde on induced alcoholic fatty liver in vitro
LIAO Yu;LI Long-hui;ZUO Guo-qing;WU Hai-feng;ZHU Zhao-jing

..............page:628-629

A brief report from The 7th National Conference on Liver Diseases & EASL Day
YUAN Ping-ge;ZHU Hong-mei;ZHANG Da-zhi

..............page:632-634

A brief report from The 7th National Conference on Liver Diseases & EASL Day
YUAN Ping-ge;ZHU Hong-mei;ZHANG Da-zhi

..............page:632-634

Effect of siRN A-mediated inhibition of nuclear transcription factor-kappa B on apoptosis of hepatocarcinoma cells
WANG Yi-lang;YAO Deng-fu;WU Wei;SAI Wen-li;QIU Li-wei;YANG Jun-ling;ZHU Jian-wei

..............page:609-613

Inhibitory effects of LNAzyme on expression of hepatitis C virus 5\' -NCR Internal Ribosome Entry Site in HepG2.9706 cells
DENG Yi-bin;NONG Le-gen;WANG Yan-fei

..............page:624-625

Effect of ligustrazine hydrocklorde on induced alcoholic fatty liver in vitro
LIAO Yu;LI Long-hui;ZUO Guo-qing;WU Hai-feng;ZHU Zhao-jing

..............page:628-629

Interferon caused dysfunction of thyroid in chronic hepatitis C patient: a case report
RAO Hui-ying;MA Hui;WEI Lai

..............page:631

Clinical evaluation of valsartan on portal hypertension in patients with hepatic cirrhosis
HUO Li-juan;ZHANG Suo-juan;LIU Ying

..............page:622-623

Study on a putative, proprotein convertase-cleaved product of HBV core protein in vitro
CHENG Jie;SHI Hong;LEI Rui-xiang;PENG Xiao-mou

..............page:595-598

The advances of antifibrosis treatment
YOU Hong;WU Peng

..............page:574-575

Effect of siRN A-mediated inhibition of nuclear transcription factor-kappa B on apoptosis of hepatocarcinoma cells
WANG Yi-lang;YAO Deng-fu;WU Wei;SAI Wen-li;QIU Li-wei;YANG Jun-ling;ZHU Jian-wei

..............page:609-613

Inhibitory effects of LNAzyme on expression of hepatitis C virus 5\' -NCR Internal Ribosome Entry Site in HepG2.9706 cells
DENG Yi-bin;NONG Le-gen;WANG Yan-fei

..............page:624-625

Interferon caused dysfunction of thyroid in chronic hepatitis C patient: a case report
RAO Hui-ying;MA Hui;WEI Lai

..............page:631

Clinical evaluation of valsartan on portal hypertension in patients with hepatic cirrhosis
HUO Li-juan;ZHANG Suo-juan;LIU Ying

..............page:622-623

Study on a putative, proprotein convertase-cleaved product of HBV core protein in vitro
CHENG Jie;SHI Hong;LEI Rui-xiang;PENG Xiao-mou

..............page:595-598

The advances of antifibrosis treatment
YOU Hong;WU Peng

..............page:574-575

Treatment of hemorrhage from gastric varices with percutaneous transhepatic variceal embolization and partial splenic embolization
ZHANG Hong-wen;YANG Xue-feng;LIU Xu-yun;DENG Xiao-jun;DENG Li-ping;XIE Wei-hua;DUAN Shi-jiao

..............page:626-627

The immunological mechanisms of liver fibrosis
CAO Yi-rong;GUO Jin-sheng

..............page:566-568

Primary hepatocelluar carcinoma with pregnancy and delivery:a case report
CAO Min-kai;HAN Guo-rong

..............page:630

Primary hepatocelluar carcinoma with pregnancy and delivery:a case report
CAO Min-kai;HAN Guo-rong

..............page:630

Quantitative evaluation of fatty liver with 1HMRS
FU Guo-li;DU Yong;YANG Han-feng

..............page:638-640

Quantitative evaluation of fatty liver with 1HMRS
FU Guo-li;DU Yong;YANG Han-feng

..............page:638-640

The immunological mechanisms of liver fibrosis
CAO Yi-rong;GUO Jin-sheng

..............page:566-568

Individualized respond guidance treatment of chronic hepatitis C with combination of peginterferon α -2a and ribavirin
CHEN Wen-li;CHEN Xiao-ping;CHEN Xue-fu;HUANG Jing;LUO Xiao-dan

..............page:585-589

Expression of nuclear factor- κB and its regulated cytokines in dendritic cells in patients with chronic severe hepatitis B and its clinical significance
QIAN Zhi-ping;LI Ning;ZHU Meng-qi;ZHENG Jian-ming;ZHANG Yu-jie;LI Qian;CHEN Ming-quan;WANG Jie-fei;SHI Guang-feng

..............page:590-594

Effect of postoperative adjuvant transarterial chemoembolization on late recurrence of hepatocellular carcinoma after radical resection
CHEN Xiao-hong;ZHANG Bo-heng;QIU Shuan-jian;FAN Jia;REN Zheng-gang;XIA Jin-lin;WANG Yan-hong;GAN Yu-hong;YIN Xin;YE Sheng-long

..............page:599-603

The importance of explorations on the pathophysiological mechanisms and treatment methods for liver fibrosis
LIU Ping

..............page:561-562

Expression of nuclear factor- κB and its regulated cytokines in dendritic cells in patients with chronic severe hepatitis B and its clinical significance
QIAN Zhi-ping;LI Ning;ZHU Meng-qi;ZHENG Jian-ming;ZHANG Yu-jie;LI Qian;CHEN Ming-quan;WANG Jie-fei;SHI Guang-feng

..............page:590-594

Effect of postoperative adjuvant transarterial chemoembolization on late recurrence of hepatocellular carcinoma after radical resection
CHEN Xiao-hong;ZHANG Bo-heng;QIU Shuan-jian;FAN Jia;REN Zheng-gang;XIA Jin-lin;WANG Yan-hong;GAN Yu-hong;YIN Xin;YE Sheng-long

..............page:599-603

Individualized respond guidance treatment of chronic hepatitis C with combination of peginterferon α -2a and ribavirin
CHEN Wen-li;CHEN Xiao-ping;CHEN Xue-fu;HUANG Jing;LUO Xiao-dan

..............page:585-589

Hepatic microdialysis technique and its application in hepatic relevant material assay
PAN Xu-wang;TIAN Jing;JIANG Xiao-qin

..............page:635-637

Treatment of hemorrhage from gastric varices with percutaneous transhepatic variceal embolization and partial splenic embolization
ZHANG Hong-wen;YANG Xue-feng;LIU Xu-yun;DENG Xiao-jun;DENG Li-ping;XIE Wei-hua;DUAN Shi-jiao

..............page:626-627

Hepatic microdialysis technique and its application in hepatic relevant material assay
PAN Xu-wang;TIAN Jing;JIANG Xiao-qin

..............page:635-637

The importance of explorations on the pathophysiological mechanisms and treatment methods for liver fibrosis
LIU Ping

..............page:561-562

Analysis of the clinical features of and responsive factors on the prognosis in patients with fulminant hepatic failure
ZHANG Lin;HAN Feng;WU Dan;ZHANG Dan;FENG Guo-he

..............page:614-617

Analysis of the clinical features of and responsive factors on the prognosis in patients with fulminant hepatic failure
ZHANG Lin;HAN Feng;WU Dan;ZHANG Dan;FENG Guo-he

..............page:614-617

Hypoxia and liver fibrosis
CHEN Ping-sheng;LI Jing

..............page:569-571

Effectiveness of p38MAPK activity during drug resistance against HepG2
TANG Peng;CHEN Wei-qing;SHEN Wen-yong

..............page:604-608

The changes of interdigestive migrating motor complex in rats with acute liver failure
LIU Mei;XU Wei-hong;DUAN Zhong-ping;CHEN Yu;ZHENG Su-jun;LIU Xu-hua;ZHANG Jing;ZHAO Jun;DING Mei;L(U) Zhi-wu

..............page:618-621

The changes of interdigestive migrating motor complex in rats with acute liver failure
LIU Mei;XU Wei-hong;DUAN Zhong-ping;CHEN Yu;ZHENG Su-jun;LIU Xu-hua;ZHANG Jing;ZHAO Jun;DING Mei;L(U) Zhi-wu

..............page:618-621

Effectiveness of p38MAPK activity during drug resistance against HepG2
TANG Peng;CHEN Wei-qing;SHEN Wen-yong

..............page:604-608

Hypoxia and liver fibrosis
CHEN Ping-sheng;LI Jing

..............page:569-571

Comments on the current diagnostic mehtods for hepatic fibrosis
XU Ming-yi;LU Lun-gen

..............page:571-573

Update on hepatic fibrosis research
XU Lie-ming

..............page:563-565

Effect of collagens and growth factors (TGF β1, PDGF-BB) on cytoskeletal reorganization and cell migration in hepatic stellate cells
LI Lei;JIANG Wei;WANG Ji-yao;YANG Chang-qing

..............page:581-584

Stimulation of human hepatic stellate cells by cytochrome P4502E1-mediated oxidative stress
LI Jing;LIU Tian-hui;YOU Hong;XU You-qing;WANG Chen

..............page:576-580

xin xi dong tai

..............page:575,580,598,613,637,640